Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic studyKimberly K. Scarsi, Charles Wira, Francesca Aweeka et al.|The Lancet HIV|2019Cited by 22
Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy VolunteersKelly E. Dooley, Radojka M. Savić, Jeong‐Gun Park et al.|Antimicrobial Agents and Chemotherapy|2015Cited by 21